Effects of Hypoxia on Adipose Tissue Expression of NFκB, IκBα, IKKγ and IKAP in Patients with Chronic Obstructive Pulmonary Disease

Cell Biochemistry and Biophysics

Volumn 66, Issue 1, 2013, Pages 7-12

  Tkacova, R ^a   Ukropec, J ^b   Skyba, P ^a   Ukropcova, B ^b   Pobeha, P ^a   Kurdiova, T ^b   Joppa, P ^a   Klimes, I ^b   Tkac, I ^a   Gasperikova, D ^b  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Adipose tissue; Chronic obstructive pulmonary disease; Hypoxia; Inhibitors of B; NF B; Systemic inflammation

Indexed keywords

EID: 84876197428     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9391-9     Document Type: Article

References (36)

1. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.
2. Trayhurn, P., & Beattie, J. H. (2001). Physiological role of adipose tissue: white adipose tissue as and endocrine and secretory organ. Proceedings of the Nutrition Society, 60, 329-339.
3. Kershaw, E. E., & Flier, J. S. (2004). Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology & Metabolism, 89, 2548-2556.
4. Trayhurn, P., & Wood, I. S. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition, 92, 347-355.
5. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., et al. (1997). Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. Journal of Clinical Endocrinology & Metabolism, 82, 4196-4200.
6. 2-regulated gene expression. FASEB Journal, 16, 1151-1162.
7. Chen, B., Lam, K. S., Wang, Y., Wu, D., Lam, M. C., Shen, J., et al. (2006). Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochemical and Biophysical Research Communications, 341, 549-556.
8. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., et al. (2007). Adipose tissue hypoxia in obesity and its impact on adipocyte dysregulation. Diabetes, 56, 901-911.
9. Trayhurn, P., Wang, B., & Wood, I. S. (2008). Hypoxia and the endocrine and signaling role of white adipose tissue. Archives of Physiology and Biochemistry, 114, 267-276.
10. Pasarica, M., Sereda, O. R., Redman, L. M., Albarado, D. C., Hymel, D. T., Roan, L. E., et al. (2009). Reduced adipose tissue oxygenation in human obesity: Evidence for rarefaction, macrophage chemotaxis, and inflammation without angiogenic response. Diabetes, 58, 718-725.
11. Franssen, F. M. E., O'Donnell, D. E., Goossens, G. H., Blaak, E. E., & Schols, A. M. (2008). Obesity and the lung: 5. Obesity and COPD. Thorax, 63, 1110-1117.
12. Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176, 532-555.
13. Karin, M. (2006). Nuclear factor-κB in cancer development and progression. Nature, 441, 431-436.
14. Himadri, P., Kumari, S. S., Chitharanjan, M., & Dhananjay, S. (2010). Role of oxidative stress and inflammation in hypoxia-induces cerebral edema: a molecular approach. High Altitude Medicine and Biology, 11, 231-244.
15. Sarada, S., Himadri, P., Mishra, C., Geetali, P., Ram, M. S., & Ilavazhagan, G. (2008). Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema. Experimental Biology and Medicine, 233, 1088-1098.
16. Cristosomo, P. R., Wang, Y., Markel, T. A., Wang, M., Lahm, T., & Meldrum, D. R. (2008). Human mesenchymal stem cells stimulated by TNF-a, LPS, or hypoxia produce growth factors by an NFκB- but not JNK-dependent mechanism. American Journal of Physiology. Cell Physiology, 294, C675-C682.
17. Ryan, S., Taylor, C., & McNicholas, W. (2005). Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation, 112, 2660-2667.
18. Ryan, S., McNicholas, W. T., & Taylor, C. T. (2007). A critical role for p38 map kinase in NF-kB signaling during intermittent hypoxia/reoxygenation. Biochemical and Biophysical Research Communications, 355, 728-733.
19. Arnaud, C., Beguin, P. C., Lantuejoul, S., Pepin, J. L., Guillermet, C., Pelli, G., et al. (2011). The inflammatory pre-atherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. American Journal of Respiratory and Critical Care Medicine, 184(6), 724-731.
20. Greenberg, H., Ye, X., Wilson, D., Htoo, A. K., Hendersen, T., & Liu, S. F. (2006). Chronic intermittent hypoxia activates nuclear factor-lB in cardiovascular tissues in vivo. Biochemical and Biophysical Research Communications, 343, 591-596.
21. Garvey, J. F., Taylor, C. T., & McNicholas, W. T. (2009). Cardiovascular disease in obstructive sleep apnoea syndrome: The role of intermittent hypoxia and inflammation. European Respiratory Journal, 33, 1195-1205.
22. Tkacova, R., Ukropec, J., Skyba, P., Ukropcova, B., Pobeha, P., Kurdiova, T., et al. (2011). Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease. Respiration, 81, 386-393.
23. Skyba, P., Ukropec, J., Pobeha, P., Ukropcova, B., Joppa, P., Kurdiova, T., et al. (2010). Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease. Mediators of Inflammation, 2010, 173498.
24. Nelson, D. E., Ihekwaba, A. E., Elliott, M., Johnson, J. R., Gibney, C. A., Foreman, B. E., et al. (2004). Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science, 22, 704-708.
25. Celli, B. R., & MacNee, W. (2004). Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. European Respiratory Journal, 23, 932-946.
26. Ukropec, J., Penesova, A., Skopkova, M., Radikova, Z., Imrich, R., Ukropcova, B., et al. (2008). Adipokine protein expression pattern ingrowth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements. Journal of Clinical Endocrinology & Metabolism, 93, 2255-2262.
27. Klein, D. (2002). Quantification using real-time PCR technology: Applications and limitations. Trends in Molecular Medicine, 8, 257-260.
28. Hay, R. T., Vuillard, L., Desterro, J. M., & Rodriguez, M. S. (1999). Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha. Philosophical Transactions of the Royal Society B: Biological Sciences, 29, 1601-1609.
29. Ryan, S., Taylor, C. T., & McNicholas, W. T. (2006). Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. American Journal of Respiratory and Critical Care Medicine, 174, 824-830.
30. Summers, L. K., Samra, J. S., Humphreys, S. M., Morris, R. J., & Frayn, K. N. (1996). Subcutaneous abdominal adipose tissue blood flow: Variation within and between subjects and relationship to obesity. Clinical Science, 91, 679-683.
31. Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007). Relationship between adipocyte size and adipokine expresion and secretion. Journal of Clinical Endocrinology & Metabolism, 92, 1023-1033.
32. Dietze, D., Ramrath, S., Ritzeler, O., Tennagels, N., Hauner, H., & Eckel, J. (2004). Inhibitor κB kinase is involved in the paracrine crosstalk between human fat and muscle cells. International Journal of Obesity and Related Metabolic Disorders, 28, 985-992.
33. Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z. W., Long, J. M., et al. (2005). IKK-β links inflammation to obesity-induced insulin resistance. Nature Medicine, 11, 191-198.
34. Baker, A. R., Harte, A. L., Howell, N., Pritlove, D. C., Ranasinghe, A. M., da Silva, N. F., et al. (2009). Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. Journal of Clinical Endocrinology & Metabolism, 94, 261-267.
35. Tkac, J., Man, S. F., & Sin, D. D. (2007). Systemic consequences of COPD. Therapeutic Advances in Respiratory Disease, 1, 47-59.
36. Sin, D. D., & Man, S. F. (2007). Systemic inflammation and mortality in chronic obstructivepulmonary disease. Canadian Journal of Physiology and Pharmacology, 85, 141-147.